Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

The FDA has expanded the label of Bayer’s kidney disease drug Kerendia to include treatment of patients with two types of heart failure.

Tomorrowland Music and 1001 Tracklists have united to launch a record label, 1001 Recordings. The venture will focus on music for the dancefloor.

Bayer AGBAYRY announced that the FDA has approved a label expansion of kidney disease drug Kerendia (finerenone). The regulatory body approved finerenone for the treatment of adult patients with ...

Being called a “billionaire’s daughter” doesn’t sit well with American tennis player Emma Navarro—the daughter of billionaire Ben Navarro. “It’s a label I don’t really like,” the ...

This is a well-written study that presents a solid genetic screen to identify regulators of adipose morphology and remodeling in zebrafish. The authors generated a rigorous screening platform based on ...

AI spots deadly heart risk most doctors can't see Model much better than doctors at identifying patients most at-risk. Date: July 3, 2025 Source: Johns Hopkins University Summary: An advanced ...

In STEMI-induced cardiogenic shock, a microaxial flow pump can unload the heart by reducing native cardiac output and pulmonary pressures while maintaining cardiac power output.